MapLight Therapeutics, Inc. (MPLT)
7.58
-0.14
(-1.81%)
USD |
NASDAQ |
Oct 30, 16:00
7.65
+0.07
(+0.92%)
Pre-Market: 20:00
MapLight Therapeutics Free Cash Flow : -175.12M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -175.12M |
| March 31, 2026 | -164.26M |
| December 31, 2025 | -138.61M |
| Date | Value |
|---|---|
| September 30, 2025 | -109.22M |
| June 30, 2025 | -97.35M |
| March 31, 2025 | -75.37M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cullinan Therapeutics, Inc. | -159.26M |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Oncolytics Biotech, Inc. | -26.53M |
| Sangamo Therapeutics, Inc. | -90.46M |
| Sarepta Therapeutics, Inc. | 58.34M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -44.87M |
| Cash from Investing (Quarterly) | 60.70M |
| Cash from Financing (Quarterly) | 0.092M |
| Free Cash Flow Per Share (Quarterly) | -0.9881 |
| Free Cash Flow to Equity (Quarterly) | -41.29M |
| Free Cash Flow to Firm (Quarterly) | -44.89M |
| Free Cash Flow Yield | -51.33% |